Search For "therapeutics"
BioAsia 2026: BioVaram's AI-Driven breakthrough aims to transform regenera
Updated : 3 weeks, 2 days ago IST
At BioAsia 2026, "TechBio Unleashed: AI, Automation & the Biology Revolution", a homegrown deep-tech startup emerged as a powerful example of India's growing biotech strength. Dr. Jagan Mohan Reddy, Founder and CEO of BioVaram (officially known as UR Advanced Therapeutics), unveiled a
Read More
BioAsia 2026: Utopia Therapeutics unveils 'Nexa' stem-cell powered gut inn
Updated : 3 weeks, 2 days ago IST
At BioAsia 2026, themed "TechBio Unleashed: AI, Automation & the Biology Revolution," innovation met deep science as inventor Dr Uday Saxena and co-inventor Dr Markandey introduced their company Utopia Therapeutics and its pioneering nutraceutical products -- Nexa Gut and Nexa Sweet.
Read More
Budget 2026 positions India to accelerate from volume-driven production to
Updated : 1 month, 1 week ago IST
The Union Health Budget 2026 has unveiled a push to the healthcare sector that will. make country self reliable and long term globally credible.
Read More
ICMTDT-2026 to Bring Global Experts to Vadodara for Multidisciplinary Dial
Updated : 1 month, 2 weeks ago IST
Vadodara (Gujarat) [India], January 29: The International Conference on Metabolism, Toxicology, Diagnostics and Therapeutics (ICMTDT-2026) will be held from January 28 to 30, 2026, at the School of Science, Navrachana University, Vadodara, Gujarat, India. The conference will bring together 5
Read More
Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuzn
Updated : 3 months, 2 weeks ago IST
Singapore, November 26: Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar d
Read More
"Revolutionizing Heart Care & Empowering Patients:" Sirolimus-Driven Ballo
Updated : 3 months, 3 weeks ago IST
San Francisco [US], November 19: In a defining chapter for global cardiovascular care, MedAlliance, the Swiss-based innovator behind the patented SELUTION Sirolimus Drug-Eluting Balloon (DEB), continues to transform the landscape of heart disease treatment following its acquisition by Cordis
Read More
Lupin Digital Health Launches VITALYFE™ AI-Powered Cardiometabolic Wellnes
Updated : 4 months ago IST
Mumbai (Maharashtra) [India], November 12: Lupin Digital Health, India's leading cardiac digital-therapeutics company, today announced the launch of VITALYFE™, an AI-powered cardiometabolic wellness platform designed to help India's working professionals reclaim their heart health. Built on
Read More
Cordis Unveiled Positive Results for Two SELUTION SLR DEB Trials
Updated : 4 months ago IST
Mumbai (Maharashtra) [India], November 11: Cordis, a global leader in interventional cardiovascular technology, announced the groundbreaking results from the SELUTION DeNovo and SELUTION4ISR trials at Transcatheter Cardiovascular Therapeutics® (TCT®) 2025, the annual scientific symposium of
Read More
Bharat Biotech launches Nucelion, the Next-Gen Cell and Gene Therapy CRDMO
Updated : 4 months, 1 week ago IST
Nucelion Therapeutics Pvt Ltd, a newly established Hyderabad-based Contract Research, Development, and Manufacturing Organisation (CRDMO) focused on cell and gene therapies, announced its formal launch on Monday.
Read More
Bynocs and Dr. Shroff's Charity Eye Hospital Collaborate to Launch Advance
Updated : 5 months, 1 week ago IST
New Delhi [India], September 22: Bynocs, a global leader in AI-powered digital therapeutics for binocular vision disorders, has partnered with Dr. Shroff's Charity Eye Hospital, one of India's most respected institutions, to inaugurate an Advanced Amblyopia & Binocular Vision Clinic.
Read More
The Avestagenome Project® and 'Longevity India' Initiative of Indian Insti
Updated : 5 months, 1 week ago IST
Bengaluru (Karnataka) [India], September 10: Avestagenome Project® International Pvt. Ltd., a trailblazer in genomics and preventive health innovation, has entered into a landmark research collaboration with the 'Longevity India' Initiative of Indian Institute of Science (IISc), India's prem
Read More
Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2
Updated : 5 months, 1 week ago IST
Pennington (New Jersey) [US] / Ahmedabad (Gujarat) [India], August 30: Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led healthcare company, today announced positive topline results from the pivotal EPICS-III Phase 2(b)/3 clinical trial. In
Read More